 |
|
Dermatologists Debate Sentinel Node Biopsy, Safety of Liposuction, and Antibiotic Prophylaxis
Lynne Lamberg
JAMA. 2000;283:2223-2224.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
San Francisco—Is sentinel node biopsy the criterion standard for staging malignant melanoma? What are the advantages and drawbacks of a hospital vs an office for performing liposuction, the nation's most common cosmetic surgical procedure? Should antibiotics be given prophylactically in conjunction with skin surgery?
The answers may hold some surprises for primary care providers who refer patients to dermatologists for the procedures in question. These issues prompted spirited debate in the current controversies symposium at the annual meeting of the American Academy of Dermatology (AAD) here in March.
The meeting set an attendance record, attracting some 9600 physicians. They included most of the nation's 7600 dermatologists, 98% percent of whom are AAD members, along with trainees and more than 2000 dermatologists from other countries.
Arguing in favor of sentinel node biopsy as a standard of care in malignant melanoma, Clark Otley, MD, an assistant professor of dermatology . . . [Full Text of this Article]
|
